Sinopharm Jumps Most in 5 Years on Coronavirus Vaccine Data

(Bloomberg) -- Sinopharm Group Co. surged by the most since April 2015 on Wednesday to help lead a rally among Chinese health-care names, as the trial results for a Covid-19 vaccine candidate rekin...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.